Icotinib versus whole-brain irradiation in patients with EGFR -mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial-Reference-Cited by-同舟云学术

Icotinib versus whole-brain irradiation in patients with EGFR -mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial

Published:2017-09 Issue:9 Volume:5 Page:707-716
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Yang Jin-Ji,Zhou Caicun,Huang Yisheng,Feng Jifeng,Lu Sun,Song Yong,Huang Cheng,Wu Gang,Zhang Li,Cheng Ying,Hu Chengping,Chen Gongyan,Zhang Li,Liu Xiaoqing,Yan Hong Hong,Tan Fen Lai,Zhong Wenzhao,Wu Yi-Long

Funder

Guangdong Provincial Key Laboratory of Lung Cancer Translational Medicine

National Health and Family Planning Commission of China

Guangzhou Science and Technology Bureau

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference30 articles.

1. Distribution of distant metastases from newly diagnosed non-small cell lung cancer;Quint;Ann Thorac Surg,1996

2. CNS metastases in non-small-cell lung cancer: Current role of EGFR-TKI therapy and future perspective;Berger;Lung Cancer,2013

3. Metastatic sites and survival in lung cancer;Riihimaki;Lung Cancer,2014